Puma Biotech (PBYI) Reports Q2 Loss, Tops Revenue Estimates
PBYIPuma Biotechnology(PBYI) ZACKS·2024-08-02 07:11

Puma Biotech (PBYI) came out with a quarterly loss of 0.05pershareversustheZacksConsensusEstimateofalossof0.05 per share versus the Zacks Consensus Estimate of a loss of 0.10. This compares to earnings of 0.10pershareayearago.Thesefiguresareadjustedfornon−recurringitems.Thisquarterlyreportrepresentsanearningssurpriseof500.10 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 50%. A quarter ago, it was expected that this biopharmaceutical company would post a loss of 0.16 per share when it actually produced a loss of $0.05, delivering a surprise of 68.75%.Over the last four quarters, the comp ...